جميع الدراسات
مُصرحالمرحلة الأولى والمرحلة الثانية (متكاملة) - أخرىتداخلي

CHEMOKINE RECEPTOR CXCR4-DIRECTED THERANOSTICS OF ADVANCED LYMPHOPROLIFERATIVE CANCERS BY RADIOPEPTIDE-BASED IMAGING AND THERAPY: THE COLPRIT PHASE I/II STUDY

This research trial, called COLPRIT, is looking for better ways to deal with advanced non-Hodgkin lymphomas, which are types of cancer affecting white blood cells. It involves using two special substances. The first, [68Ga]Ga-PentixaFor, helps doctors accurately see the cancer inside the body. The second, [90Y]Y-PentixaTher, is designed to deliver targeted radiation directly to the cancer cells. This is a two-part study. The first part focuses on finding the safest dose for the treatment. The second part will then look at how well this treatment shrinks or controls the cancer. It's hoped this approach could lead to more effective and precise treatments.

نظرة سريعة

الحالة
مُصرح
المرحلة
المرحلة الأولى والمرحلة الثانية (متكاملة) - أخرى
الراعي
Klinikum rechts der Isar der TU Muenchen AöR
الهدف من التسجيل
38
ابدأ
14 أكتوبر 2024

ما هو موضوع هذه الدراسة؟

This study is called COLPRIT, and it's looking into new ways to treat advanced non-Hodgkin lymphomas. These are cancers that start in white blood cells called lymphocytes, which are an important part of your immune system. When cancer is 'advanced', it means it has spread or is difficult to treat with standard methods.

The researchers are testing a new approach called 'theranostics'. This word comes from 'diagnosis' (finding out what's wrong) and 'therapeutics' (treating it). It means they are using substances that can both help to pinpoint the cancer and then also treat it. For finding the cancer, they use something called [68Ga]Ga-PentixaFor. This substance attaches to certain markers on cancer cells, making them light up on special scans, so doctors can see exactly where they are. For treatment, they use [90Y]Y-PentixaTher, which is designed to deliver targeted radiation directly to these marked cancer cells, hopefully causing less damage to healthy parts of the body.

This study has two main parts. The first part (Phase I) is about finding the safest dose of the treatment, making sure it's well-tolerated by patients. Once a safe dose is found, the second part (Phase II) will look at how effective this treatment is at shrinking the cancer or stopping it from growing. They will also keep a close eye on any side effects and how patients are generally doing. This research is important because it could lead to new, more precise ways to manage advanced non-Hodgkin lymphomas.

النقاط الرئيسية

  • This study is testing a new way to find and treat advanced non-Hodgkin lymphoma.
  • It uses special substances that can both locate and treat cancer cells.
  • The study aims to find a safe dose and see how well the treatment works.
  • It's open to adults aged 18 and over, both men and women.
  • Participation involves tests, treatment, and regular check-ups to monitor your health.

من قد يكون مؤهلاً؟

To be considered for this study, you must be 18 years old or older. There is no upper age limit, meaning older adults can also take part.

This study is open to both men and women.

Apart from age and sex, specific details about your type of non-Hodgkin lymphoma and your general health would be checked by the study doctors to see if this treatment is right for you.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. هل عمرك 18 سنة أو أكثر؟
  2. Do you have advanced non-Hodgkin lymphoma?
  3. هل تستطيع حضور الزيارات المنتظمة للمستشفى؟
  4. Are you prepared to potentially receive a new, experimental treatment?
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

If you decide to take part in this study, you'll first have a series of check-ups and tests. These tests may include scans to understand your cancer better and make sure the treatment is suitable for you. You will receive the study treatment, which involves an injection of the special substances mentioned. The doctors will closely monitor you during and after the treatment. This will involve regular visits to the hospital for blood tests, scans, and check-ups to see how you are responding to the treatment and to keep an eye on any side effects. The exact number of visits and the total duration in the study will vary for each patient, but you will be fully informed of the schedule if you decide to participate. You will have regular contact with the study team throughout.

المخاطر والفوائد المحتملة

Patients joining this study might experience potential benefits, such as receiving a new, experimental treatment for their advanced non-Hodgkin lymphoma that isn't widely available yet. This treatment is designed to specifically target cancer cells, which could lead to fewer side effects compared to traditional treatments. However, as with all medical treatments, there are potential risks and side effects, and these will be fully explained to you before you agree to take part. The study team will closely monitor your health to manage any side effects. It’s important to remember that you can decide to stop participating in the study at any time, for any reason, without it affecting your usual medical care.

المواقع (1)

بعض مواقع الأماكن تقريبية. نحن نعمل على تحسين ذلك — يرجى التحقق مع فريق التجربة قبل السفر.
  • —
    غير مؤكد
    ألمانيا

أسئلة شائعة

What is non-Hodgkin lymphoma?

Non-Hodgkin lymphoma is a type of cancer that starts in white blood cells called lymphocytes, which are part of your body's immune system.

ماذا يعني السرطان "المتقدم" في هذه الدراسة؟

'Advanced' means the cancer may have spread or is harder to treat with standard methods.

What is 'theranostics'?

It's a combined approach where special substances are used both to find the cancer (diagnosis) and then to treat it (therapeutics).

Will I receive radiation treatment?

Yes, part of this experimental treatment involves delivering targeted radiation directly to the cancer cells using a special substance.

هل يمكنني مغادرة الدراسة إذا غيرت رأيي؟

Yes, you can choose to stop participating in the study at any time, for any reason, without affecting your regular medical care.

كيفية معرفة المزيد

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.